Skip to contentB
BioCardia, Inc.
B
BCDABioCardia, Inc. Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$5.00K$5.00Kderived−86.8% vs Q4 2012 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived$3,000N/M The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCardia, Inc. · CIK 925741 · Engraved from SEC EDGAR
Operating Cash Flowderived$32,000−92.8% ended Dec 31, 2013 · filed Mar 24, 2014 · 83 d after period end